H.C. Wainwright Affirms Buy Rating on Alto Neuroscience (ANRO), Sets $10 PT
On Tuesday, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Alto Neuroscience Inc. (NYSE:ANRO) and set a price target of $10.00.
June 3rd, 2025 - News
April 10th, 2024 - Hedge Funds Insider Trading News
Returns since its inception in May 2014 (through February 19th, 2025)